tiprankstipranks
Advertisement
Advertisement

AUPH Stock Latest News

Aurinia presents new analysis of AURORA 1 Phase 3 study of Lupkynis
The FlyAurinia presents new analysis of AURORA 1 Phase 3 study of Lupkynis
8h ago
AUPH
Morning Movers: Macy’s and Medtronic rise after quarterly reports
PremiumThe Fly
Morning Movers: Macy’s and Medtronic rise after quarterly reports
1d ago
M
GME
Aurinia Pharmaceuticals up 4% in pre-market after insider transactions
PremiumThe Fly
Aurinia Pharmaceuticals up 4% in pre-market after insider transactions
1d ago
AUPH
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
PremiumCompany Announcements
Aurinia Pharmaceuticals Completes Acquisition of Kezar Life Sciences
24d ago
8K
AUPH
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
PremiumThe Fly
Aurinia Pharmaceuticals reports Q1 EPS 25c, consensus 20c
28d ago
AUPH
Aurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
PremiumThe FlyAurinia backs FY26 revenue view $315M-$325M, consensus $326.22M
28d ago
AUPH
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
Premium
Company Announcements
Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline
2M ago
8K
AUPH
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
Premium
The Fly
Kezar Life Sciences takeover valuation ‘makes sense,’ says Jefferies
2M ago
KZR
AUPH
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
PremiumThe Fly
Midday Fly By: Sysco buying Restaurant Depot, Uber to acquire Blacklane
2M ago
IQ
SR
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
PremiumCompany Announcements
Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal
2M ago
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
PremiumThe Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
2M ago
KZR
AUPH
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
PremiumThe Fly
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
2M ago
KZR
AUPH
Aurinia Reshapes C-Suite as Investor Kevin Tang Takes CEO Role Without Pay
PremiumCompany AnnouncementsAurinia Reshapes C-Suite as Investor Kevin Tang Takes CEO Role Without Pay
2M ago
AUPH
MKT Capital ‘applauds’ Aurinia’s management transition
Premium
The Fly
MKT Capital ‘applauds’ Aurinia’s management transition
2M ago
AUPH
Aurinia Reshapes Executive Team as Board Chair Kevin Tang Becomes CEO
Premium
Company Announcements
Aurinia Reshapes Executive Team as Board Chair Kevin Tang Becomes CEO
2M ago
AUPH
Aurinia Pharmaceuticals announces Tang to succeed Greenleaf as CEO
PremiumThe Fly
Aurinia Pharmaceuticals announces Tang to succeed Greenleaf as CEO
2M ago
AUPH
Aurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
PremiumCompany Announcements
Aurinia Pharmaceuticals Earnings Call Highlights Growth And Risks
3M ago
AUPH
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
PremiumCompany Announcements
Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook
3M ago
AUPH
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
PremiumCompany Announcements
Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook
3M ago
AUPH
Aurinia Pharmaceuticals reports Q4 EPS $1.53, consensus 22c
PremiumThe FlyAurinia Pharmaceuticals reports Q4 EPS $1.53, consensus 22c
3M ago
AUPH
Aurinia Pharmaceuticals sees 2026 revenue $315M-$-325M, consensus $326.8M
Premium
The Fly
Aurinia Pharmaceuticals sees 2026 revenue $315M-$-325M, consensus $326.8M
3M ago
AUPH
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >